{"id":"W4393965986","doi":"10.1016/s0140-6736(24)00317-9","title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Meso Scale Diagnostics","keywords":"Pembrolizumab; Medicine; Placebo; Cervical cancer; Chemoradiotherapy; Clinical trial; Internal medicine; Oncology; Double blind; Cancer; Immunotherapy; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001902276,0.002085741,0.003938193,0.0006304813,0.0005648524,0.001059257,0.001177431,0.002888994,0.01288196],"category_scores_gemma":[0.001791126,0.000971162,0.002257785,0.0005069741,0.001505407,0.001365723,0.0004675307,0.003572888,0.002062598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007848267,"about_ca_system_score_gemma":0.001187993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139586,"about_ca_topic_score_gemma":0.00296272,"domain_scores_codex":[0.9993269,0.0003182187,0.00004394985,0.0001431341,0.00004280004,0.00012503],"domain_scores_gemma":[0.9993954,0.0002139708,0.0001180223,0.0000485969,0.00003524155,0.0001887331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9841251,0.003587242,0.00009065587,0.0007622467,0.0005088252,0.00002063595,0.00002872676,0.000135661,0.001562419,0.0001041489,0.0006461227,0.008428166],"study_design_scores_gemma":[0.9718432,0.02702448,0.0002754431,0.00002522882,0.0001740667,0.00001015817,0.000008923957,0.0001143986,0.0001238904,0.00007770868,0.00031525,0.000007255077],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9485168,0.01751941,0.002102794,0.001968164,0.003150311,0.01689472,0.002741465,0.000505195,0.006601127],"genre_scores_gemma":[0.9592658,0.00737797,0.003342102,0.002218812,0.000934095,0.01516257,0.001314019,0.00005870537,0.01032594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01288196,"threshold_uncertainty_score":0.04309446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0738478402354054,"score_gpt":0.4051979508818233,"score_spread":0.3313501106464179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}